University of Southern California
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).
University of Southern California: 617 sponsored US clinical trials, 97 recruiting.
University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
617 total, page 7 of 13
Effects of Vitamin B12 Treatment in Singers
NCT03437824
Addressing Uncontrolled Diabetes in Primary Care: A Lifestyle Redesign Approach
NCT03293914
Topical Treatment and Prevalence of P. Acnes
NCT03257202
Movement-based Infant Intervention
NCT03082313
Expanding Access to Home-Based Palliative Care
NCT03128060
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
NCT03284346
Validation of a Noninvasive Automated Blood Pressure Device
NCT03566888
Questionnaires and Cognitive Assessments Following Mammography
NCT03412370
TExT-MED + FANS Full Trial
NCT03178773
Blue Star Cares: Innovative Approaches to Helping Military-Connected Caregivers
NCT03336190
Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer
NCT03091816
Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma
NCT02968680
Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery
NCT03111186
Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer
NCT03176979
Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent
NCT03146871
Study of myMS in Participants With a Diagnosis of Multiple Sclerosis
NCT03111394
Specialized Technology Education for Pumps & Pens in Underserved Populations With Diabetes
NCT04550585
Rice Bran Supplementation in Treated HIV Infection
NCT02922907
The Bed Rest Avoidance Study
NCT04006990
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
NCT03049618
Application of Behavioral Economics to Improve eConsult
NCT03784950
Targeted Enteral Nutrient Delivery: A Prospective Randomized Study
NCT03064347
Patient Adherence to Acupuncture Treatment
NCT03645083
Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With Cancer
NCT03057639
Gentamicin for RDEB
NCT03012191
Pilot Study to Examine Health Effects of Daylight Exposure on Dementia Patients
NCT03483896
Behavioral Insights to Encourage Judicious Prescribing of Opioids
NCT02790476
Memory Improvement Through Nicotine Dosing (MIND) Study
NCT02720445
Effects of e-Cigarettes on Nicotine Withdrawal
NCT03098004
Measuring Parkinson's Disease With Tear Fluid
NCT03037463
NK Cell Activity in Smokers Screened for Lung Cancer
NCT02840578
Alzheimer's Disease Neuroimaging Initiative 3
NCT02854033
Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer
NCT03137706
Healthy Eating Through Reduction Of Excess Sugar
NCT02948647
Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
NCT02960308
Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy
NCT02960282
The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion
NCT03104816
Home-Based Palliative Care Impact on Providers
NCT06140004
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
NCT02809690
Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound
NCT02902562
Neural Mechanisms of Muscle Control in Individuals With Knee Pain
NCT02854774
Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study
NCT02726906
Cystic Breast Masses by Contrast Enhanced Ultrasound (CEUS)
NCT02887937
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
NCT02259725
Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients
NCT02970617
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer
NCT02767921
High Definition Single Cell Analysis in Colorectal Cancer
NCT02809716
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
NCT02850146
Sensorimotor Changes in Stroke Following Mindfulness
NCT03534856
Exercise Program During Chemotherapy in Metastatic Colorectal Cancer
NCT03111823
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 83 |
| Phase 2 | 90 |
| Phase 3 | 9 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the University of Southern California pipeline
97 recruiting of 617 indexed (16% open); 361 completed (59%).
Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Southern California: open-pipeline peers nationwide
Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 617 trials (± recruiting share)
- Baylor College of Medicine · 616 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Youngstown State University · 16% recruiting · 19 trials
- Roswell Park Cancer Institute · 16% recruiting · 365 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- University of Oregon · 16% recruiting · 63 trials
Related
What to do with this University of Southern California page
617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.
- 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Southern California pipeline card: 617 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.